ATE471956T1 - Verzweigte polyalkylenglykole - Google Patents
Verzweigte polyalkylenglykoleInfo
- Publication number
- ATE471956T1 ATE471956T1 AT02712277T AT02712277T ATE471956T1 AT E471956 T1 ATE471956 T1 AT E471956T1 AT 02712277 T AT02712277 T AT 02712277T AT 02712277 T AT02712277 T AT 02712277T AT E471956 T1 ATE471956 T1 AT E471956T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- branched polyalkylene
- polyalkylene glycols
- reactivity
- polyalkylene glycol
- Prior art date
Links
- 229920001515 polyalkylene glycol Polymers 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000009257 reactivity Effects 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/3311—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/641—Branched, dendritic or hypercomb peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001021616 | 2001-01-30 | ||
| PCT/JP2002/000709 WO2002060978A1 (en) | 2001-01-30 | 2002-01-30 | Branched polyalkylene glycols |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE471956T1 true ATE471956T1 (de) | 2010-07-15 |
Family
ID=18887145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02712277T ATE471956T1 (de) | 2001-01-30 | 2002-01-30 | Verzweigte polyalkylenglykole |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7291713B2 (de) |
| EP (1) | EP1400550B1 (de) |
| JP (1) | JP4152187B2 (de) |
| AT (1) | ATE471956T1 (de) |
| CA (1) | CA2436623C (de) |
| DE (1) | DE60236796D1 (de) |
| WO (1) | WO2002060978A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1446438A2 (de) | 2001-11-07 | 2004-08-18 | Nektar Therapeutics Al, Corporation | Verzweigte polymere und ihre konjugate |
| MXPA05007151A (es) | 2002-12-31 | 2005-09-21 | Nektar Therapeutics Al Corp | Polimeros terminados en maleimida hidroliticamente estables. |
| US7432331B2 (en) | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
| US7153905B2 (en) * | 2003-03-21 | 2006-12-26 | The General Hospital Corporation | Hyperbranched dendron and methods of synthesis and use thereof |
| US7947261B2 (en) | 2003-05-23 | 2011-05-24 | Nektar Therapeutics | Conjugates formed from polymer derivatives having particular atom arrangements |
| EP2644206B1 (de) | 2003-05-23 | 2019-04-03 | Nektar Therapeutics | PEG-Derivative die zwei PEG Ketten enthalten |
| US8012488B2 (en) * | 2005-02-18 | 2011-09-06 | Nof Corporation | Polyoxyalkylene derivative |
| US20060233740A1 (en) * | 2005-03-23 | 2006-10-19 | Bossard Mary J | Conjugates of an hGH moiety and a polymer |
| US8568705B2 (en) | 2005-07-18 | 2013-10-29 | Nektar Therapeutics | Method for preparing branched functionalized polymers using branched polyol cores |
| DE102005041570A1 (de) | 2005-09-01 | 2007-03-22 | Celares Gmbh | Hoch verzweigte Reagenzien zur Modifaktion von Biopharmazeutika, deren Herstellung und Anwendung |
| EP3222142A1 (de) * | 2006-02-28 | 2017-09-27 | Kodiak Sciences Inc. | Acryloyloxyethylphosphorylcholin-haltige polymerkonjugate und deren herstellung |
| JP5515224B2 (ja) | 2007-02-28 | 2014-06-11 | 日油株式会社 | 多分岐鎖ポリオキシアルキレン誘導体 |
| CA2707979A1 (en) * | 2007-12-13 | 2009-06-18 | Biovectra Inc. | Polypeptides modified by protein trans-splicing technology |
| US8476404B1 (en) * | 2008-07-04 | 2013-07-02 | Bhalchandra Shripad Lele | Selectively functionalized polyhydric compounds |
| JP5287057B2 (ja) * | 2008-09-05 | 2013-09-11 | Ｊｓｒ株式会社 | ポリアミノ酸誘導体及び共重合体の製造方法 |
| ES2673993T3 (es) * | 2008-12-23 | 2018-06-26 | Shrieve Chemical Products, Inc. | Composición lubricante para refrigerantes |
| EP2552998A4 (de) * | 2010-03-30 | 2013-11-06 | Spago Imaging Ab | Kompakte, verzweigte polyethylenglycolderivate |
| JP5825507B2 (ja) * | 2010-06-25 | 2015-12-02 | 日油株式会社 | 分岐型ヘテロポリエチレングリコール |
| US10040761B2 (en) | 2010-06-25 | 2018-08-07 | Nof Corporation | Branched hetero polyethylene glycol and intermediate |
| JP6051998B2 (ja) | 2012-03-30 | 2016-12-27 | 日油株式会社 | マルチアーム型ポリエチレングリコール誘導体、その中間体及び製造方法 |
| WO2015109095A1 (en) | 2014-01-16 | 2015-07-23 | Shrieve Chemical Products, Inc. | Desicating synthetic refrigeration lubricant composition |
| KR102542988B1 (ko) * | 2018-03-13 | 2023-06-13 | 니치유 가부시키가이샤 | 주쇄 및 측쇄에 단분산 폴리에틸렌 글리콜을 가지는 헤테로이관능성 화합물 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH865367D (de) * | 1966-07-06 | |||
| JPH01153088A (ja) | 1987-12-09 | 1989-06-15 | Mihama Hisaharu | 修飾酵素 |
| JP2997004B2 (ja) | 1989-05-26 | 2000-01-11 | 住友製薬株式会社 | ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法 |
| US5342940A (en) * | 1989-05-27 | 1994-08-30 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, process for preparing the same |
| US6093391A (en) * | 1992-10-08 | 2000-07-25 | Supratek Pharma, Inc. | Peptide copolymer compositions |
| EP0619730B1 (de) * | 1992-10-08 | 2000-12-27 | Supratek Pharma Inc. | Zusammensetzung von in mizellen eingeschlossenen antineoplastischen wirkstoffen |
| US5919455A (en) * | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5731945A (en) * | 1995-02-22 | 1998-03-24 | International Business Machines Corporation | Multichip semiconductor structures with consolidated circuitry and programmable ESD protection for input/output nodes |
| IT1277596B1 (it) | 1995-09-15 | 1997-11-11 | Bracco Spa | Composti macromolecolari di tipo dendrimerico |
| JP3943162B2 (ja) * | 1996-02-28 | 2007-07-11 | 旭化成ケミカルズ株式会社 | 接着性付与剤組成物及びそれを含有するプラスチゾル組成物 |
| TW517067B (en) | 1996-05-31 | 2003-01-11 | Hoffmann La Roche | Interferon conjugates |
| JP3092530B2 (ja) * | 1996-11-05 | 2000-09-25 | 日本油脂株式会社 | コハク酸イミジル基置換ポリオキシアルキレン誘導体の製造方法 |
| JP3092531B2 (ja) | 1996-11-05 | 2000-09-25 | 日本油脂株式会社 | コハク酸イミジル基置換ポリオキシアルキレン誘導体の製造方法 |
| US6258351B1 (en) * | 1996-11-06 | 2001-07-10 | Shearwater Corporation | Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels |
| JP4078032B2 (ja) | 1998-03-12 | 2008-04-23 | ネクター セラピューティックス エイエル，コーポレイション | 近位の反応性基を持つポリ（エチレングリコール）誘導体 |
| EE05214B1 (et) | 1998-04-28 | 2009-10-15 | Applied Research Systems ARS Holding N.V. | Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon |
| JP2000191700A (ja) | 1998-12-28 | 2000-07-11 | Kyowa Hakko Kogyo Co Ltd | 持続型消化管運動ペプチド |
| JP3181276B2 (ja) * | 1999-08-31 | 2001-07-03 | 科学技術振興事業団 | 樹枝状分岐構造を持つ両親媒性化合物 |
| AU2223401A (en) | 1999-12-24 | 2001-07-09 | Kyowa Hakko Kogyo Co. Ltd. | Branched polyalkylene glycols |
-
2002
- 2002-01-30 AT AT02712277T patent/ATE471956T1/de not_active IP Right Cessation
- 2002-01-30 CA CA2436623A patent/CA2436623C/en not_active Expired - Fee Related
- 2002-01-30 JP JP2002561543A patent/JP4152187B2/ja not_active Expired - Fee Related
- 2002-01-30 EP EP02712277A patent/EP1400550B1/de not_active Expired - Lifetime
- 2002-01-30 DE DE60236796T patent/DE60236796D1/de not_active Expired - Lifetime
- 2002-01-30 US US10/470,680 patent/US7291713B2/en not_active Expired - Fee Related
- 2002-01-30 WO PCT/JP2002/000709 patent/WO2002060978A1/ja not_active Ceased
-
2007
- 2007-10-23 US US11/877,011 patent/US7547765B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20050063936A1 (en) | 2005-03-24 |
| US7291713B2 (en) | 2007-11-06 |
| WO2002060978A1 (en) | 2002-08-08 |
| CA2436623C (en) | 2011-08-02 |
| EP1400550A1 (de) | 2004-03-24 |
| EP1400550A4 (de) | 2005-10-26 |
| EP1400550B1 (de) | 2010-06-23 |
| JP4152187B2 (ja) | 2008-09-17 |
| US7547765B2 (en) | 2009-06-16 |
| CA2436623A1 (en) | 2002-08-08 |
| JPWO2002060978A1 (ja) | 2004-06-03 |
| US20080125350A1 (en) | 2008-05-29 |
| DE60236796D1 (de) | 2010-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE471956T1 (de) | Verzweigte polyalkylenglykole | |
| ATE522563T1 (de) | Verzweigte polyalkylenglykole | |
| MX353234B (es) | Variantes de polipeptidos con función efectora alterada. | |
| PT2241575E (pt) | Polipéptidos de fusão que contêm o igf-1 e utilizações terapêuticas desses polipéptidos | |
| EP2360259A3 (de) | Promyostatinpeptide und Methoden für deren Verwendung | |
| NZ521396A (en) | Fusion proteins comprising two or more Neisseria polypeptides | |
| IL161016A (en) | Polypeptides capable of ang-2 binding | |
| NO2017028I2 (no) | eftrenonacog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet. | |
| WO2005021592A3 (en) | Enhancing the circulating half-life of interleukin-2 proteins | |
| HRP20090245T1 (en) | Pyy agonists and uses thereof | |
| EP2298331A3 (de) | Verwendung von Transthyretinpeptid-/-proteinfusionen zur Erhöhung der Serumshalbwertszeit von pharmakologisch aktiven Peptiden/Proteinen | |
| WO2006031370A3 (en) | Polypeptide variants with altered effector function | |
| ATE368053T1 (de) | Antimikrobielle peptide | |
| ATE542137T1 (de) | Immunocytokine mit modulierter selektivität | |
| UA84830C2 (uk) | Розчинний рецептор інтерлейкіну-20 | |
| EP2343318A3 (de) | Antikörper die an ein C-terminales Fragment des Apolipoproteins E binden | |
| SG158141A1 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
| HK1044966A1 (zh) | C端蛋白标签 | |
| WO2002101052A3 (en) | Salutaridinol 7-o-acetyltransferase and derivatives thereof | |
| ITRM990803A0 (it) | Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono. | |
| DE69720335D1 (de) | Recombinante Fructosyl-Aminosäure-Oxidase | |
| EP1700913A4 (de) | Fluoreszenzproteine | |
| ATE474589T1 (de) | Angiogene peptide und ihre verwendungen | |
| WO2004017992A3 (en) | Ptk7 protein involvement in carcinoma | |
| MXPA05008785A (es) | Esteres de polietilen glicol activados. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |